When rejuvenation is a problem: Challenges of modeling late-onset neurodegenerative disease

Development (Cambridge)

Volumn 142, Issue 18, 2015, Pages 3085-3089

  Vera, Elsa ^a   Studer, Lorenz ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Aging; Disease modeling; Rejuvenation

Indexed keywords

AGING; ARTICLE; DEGENERATIVE DISEASE; DISEASE COURSE; DISEASE MODEL; FETUS; HUMAN; HUMAN CELL; MOLECULAR MODEL; NONHUMAN; NUCLEAR REPROGRAMMING; PARKINSON DISEASE; PHENOTYPE; PRIORITY JOURNAL; BIOLOGICAL MODEL; LATE ONSET DISORDER; PATHOPHYSIOLOGY; PHYSIOLOGY;

AGING; HUMANS; LATE ONSET DISORDERS; MODELS, BIOLOGICAL; NEURODEGENERATIVE DISEASES; PHENOTYPE;

EID: 84942162882     PISSN: 09501991     EISSN: 14779129     Source Type: Journal    
DOI: 10.1242/dev.120667     Document Type: Article

References (44)

1. Agarwal, S., Loh, Y.-H., McLoughlin, E. M., Huang, J., Park, I.-H., Miller, J. D., Huo, H., Okuka, M., Dos Reis, R. M., Loewer, S. et al. (2010). Telomere elongation in induced pluripotent stem cells from dyskeratosis congenita patients. Nature 464, 292-296.
2. Andrade, L. N., Nathanson, J. L., Yeo, G. W., Menck, C. F. M. and Muotri, A. R. (2012). Evidence for premature aging due to oxidative stress in iPSCs from Cockayne syndrome. Hum. Mol. Genet. 21, 3825-3834.
3. Baek, J.-H., Schmidt, E., Viceconte, N., Strandgren, C., Pernold, K., Richard, T. J. C., Van Leeuwen, F. W., Dantuma, N. P., Damberg, P., Hultenby, K. et al. (2015). Expression of progerin in aging mouse brains reveals structural nuclear abnormalities without detectible significant alterations in gene expression, hippocampal stem cells or behavior. Hum. Mol. Genet. 24, 1305-1321.
4. Batista, L. F. Z., Pech, M. F., Zhong, F. L., Nguyen, H. N., Xie, K. T., Zaug, A. J., Crary, S. M., Choi, J., Sebastiano, V., Cherry, A. et al. (2011). Telomere shortening and loss of self-renewal in dyskeratosis congenita induced pluripotent stem cells. Nature 474, 399-402.
5. Byers, B., Cord, B., Nguyen, H. N., Schüle, B., Fenno, L., Lee, P. C., Deisseroth, K., Langston, J. W., Pera, R. R. and Palmer, T. D. (2011). SNCA triplication Parkinson’s patient’s iPSC-derived DA neurons accumulate alpha-synuclein and are susceptible to oxidative stress. PLoS ONE 6, e26159.
6. Chin-Chan, M., Navarro-Yepes, J. and Quintanilla-Vega, B. (2015). Environmental pollutants as risk factors for neurodegenerative disorders: Alzheimer and Parkinson diseases. Front. Cell Neurosci. 9, 124.
7. Cooper, O., Seo, H., Andrabi, S., Guardia-Laguarta, C., Graziotto, J., Sundberg, M., McLean, J. R., Carrillo-Reid, L., Xie, Z., Osborn, T. et al. (2012). Pharmacological rescue of mitochondrial deficits in iPSC-derived neural cells from patients with familial Parkinson’s disease. Sci. Transl. Med. 4, 141ra90.
8. Dechat, T., Adam, S. A. and Goldman, R. D. (2009). Nuclear lamins and chromatin: when structure meets function. Adv. Enzyme Regul. 49, 157-166.
9. Devine, M. J., Ryten, M., Vodicka, P., Thomson, A. J., Burdon, T., Houlden, H., Cavaleri, F., Nagano, M., Drummond, N. J., Taanman, J.-W. et al. (2011). Parkinson’s disease induced pluripotent stem cells with triplication of the alphasynuclein locus. Nat. Commun. 2, 440.
10. Ebert, A. D., Yu, J., Rose, F. F., Jr, Mattis, V. B., Lorson, C. L., Thomson, J. A. and Svendsen, C. N. (2009). Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature 457, 277-280.
11. Frobel, J., Hemeda, H., Lenz, M., Abagnale, G., Joussen, S., Denecke, B., Saric, T., Zenke, M. and Wagner, W. (2014). Epigenetic rejuvenation of mesenchymal stromal cells derived from induced pluripotent stem cells. Stem Cell Rep. 3, 414-422.
12. Goedert, M., Spillantini, M. G., Del Tredici, K. and Braak, H. (2013). 100 years of Lewy pathology. Nat. Rev. Neurol. 9, 13-24.
13. Imaizumi, Y., Okada, Y., Akamatsu, W., Koike, M., Kuzumaki, N., Hayakawa, H., Nihira, T., Kobayashi, T., Ohyama, M., Sato, S. et al. (2012). Mitochondrial dysfunction associated with increased oxidative stress and alpha-synuclein accumulation in PARK2 iPSC-derived neurons and postmortem brain tissue. Mol. Brain 5, 35.
14. Jin, K. (2010). Modern biological theories of aging. Aging Dis. 1, 72-74.
15. Jucker, M. (2010). The benefits and limitations of animal models for translational research in neurodegenerative diseases. Nat. Med. 16, 1210-1214.
16. Keating, D. J. (2008). Mitochondrial dysfunction, oxidative stress, regulation of exocytosis and their relevance to neurodegenerative diseases. J. Neurochem. 104, 298-305.
17. Kriks, S., Shim, J.-W., Piao, J., Ganat, Y. M., Wakeman, D. R., Xie, Z., Carrillo- Reid, L., Auyeung, G., Antonacci, C., Buch, A. et al. (2011). Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson’s disease. Nature 480, 547-551.
18. Lafaille, F. G., Pessach, I. M., Zhang, S.-Y., Ciancanelli, M. J., Herman, M., Abhyankar, A., Ying, S.-W., Keros, S., Goldstein, P. A., Mostoslavsky, G. et al. (2012). Impaired intrinsic immunity to HSV-1 in human iPSC-derived TLR3- deficient CNS cells. Nature 491, 769-773.
19. Lapasset, L., Milhavet, O., Prieur, A., Besnard, E., Babled, A., Ait-Hamou, N., Leschik, J., Pellestor, F., Ramirez, J.-M., De Vos, J. et al. (2011). Rejuvenating senescent and centenarian human cells by reprogramming through the pluripotent state. Genes Dev. 25, 2248-2253.
20. Le, W., Sayana, P. and Jankovic, J. (2014). Animal models of Parkinson’s disease: a gateway to therapeutics? Neurotherapeutics 11, 92-110.
21. Lee, G., Papapetrou, E. P., Kim, H., Chambers, S. M., Tomishima, M. J., Fasano, C. A., Ganat, Y. M., Menon, J., Shimizu, F., Viale, A. et al. (2009). Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs. Nature 461, 402-406.
22. Lee, G., Ramirez, C. N., Kim, H., Zeltner, N., Liu, B., Radu, C., Bhinder, B., Kim, Y. J., Choi, I. Y., Mukherjee-Clavin, B. et al. (2012a). Large-scale screening using familial dysautonomia induced pluripotent stem cells identifies compounds that rescue IKBKAP expression. Nat. Biotechnol. 30, 1244-1248.
23. Lee, Y., Dawson, V. L. and Dawson, T. M. (2012b). Animal models of Parkinson’s disease: vertebrate genetics. Cold Spring Harb. Perspect. Med. 2, pii: a009324.
24. Liu, G.-H., Barkho, B. Z., Ruiz, S., Diep, D., Qu, J., Yang, S.-L., Panopoulos, A. D., Suzuki, K., Kurian, L.,Walsh, C. et al. (2011). Recapitulation of premature ageing with iPSCs from Hutchinson-Gilford progeria syndrome. Nature 472, 221-225.
25. Liu, G.-H., Qu, J., Suzuki, K., Nivet, E., Li, M., Montserrat, N., Yi, F., Xu, X., Ruiz, S., Zhang, W. et al. (2012). Progressive degeneration of human neural stem cells caused by pathogenic LRRK2. Nature 491, 603-607.
26. López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M. and Kroemer, G. (2013). The hallmarks of aging. Cell 153, 1194-1217.
27. Mahmoudi, S. and Brunet, A. (2012). Aging and reprogramming: a two-way street. Curr. Opin. Cell Biol. 24, 744-756.
28. Mariani, J., Simonini, M. V., Palejev, D., Tomasini, L., Coppola, G., Szekely, A. M., Horvath, T. L. and Vaccarino, F. M. (2012). Modeling human cortical development in vitro using induced pluripotent stem cells. Proc. Natl. Acad. Sci. USA 109, 12770-12775.
29. Marion, R. M., Strati, K., Li, H., Tejera, A., Schoeftner, S., Ortega, S., Serrano, M. and Blasco, M. A. (2009). Telomeres acquire embryonic stem cell characteristics in induced pluripotent stem cells. Cell Stem Cell 4, 141-154.
30. Merkle, F. T. and Eggan, K. (2013). Modeling human disease with pluripotent stem cells: from genome association to function. Cell Stem Cell 12, 656-668.
31. Miller, J. D., Ganat, Y. M., Kishinevsky, S., Bowman, R. L., Liu, B., Tu, E. Y., Mandal, P. K., Vera, E., Shim, J.-W., Kriks, S. et al. (2013). Human iPSC-based modeling of late-onset disease via progerin-induced aging. Cell Stem Cell 13, 691-705.
32. Reinhardt, P., Schmid, B., Burbulla, L. F., Schöndorf, D. C., Wagner, L., Glatza, M., Höing, S., Hargus, G., Heck, S. A., Dhingra, A. et al. (2013). Genetic correction of a LRRK2 mutation in human iPSCs links parkinsonian neurodegeneration to ERK-dependent changes in gene expression. Cell Stem Cell 12, 354-367.
33. Sánchez-Danés, A., Richaud-Patin, Y., Carballo-Carbajal, I., Jiménez-Delgado, S., Caig, C., Mora, S., Di Guglielmo, C., Ezquerra, M., Patel, B., Giralt, A. et al. (2012). Disease-specific phenotypes in dopamine neurons from human iPSbased models of genetic and sporadic Parkinson’s disease. EMBO Mol. Med. 4, 380-395.
34. Sanders, L. H., Laganiére, J., Cooper, O., Mak, S. K., Vu, B. J., Huang, Y. A., Paschon, D. E., Vangipuram, M., Sundararajan, R., Urnov, F. D. et al. (2014). LRRK2 mutations cause mitochondrial DNA damage in iPSC-derived neural cells from Parkinson’s disease patients: reversal by gene correction. Neurobiol. Dis. 62, 381-386.
35. Seibler, P., Graziotto, J., Jeong, H., Simunovic, F., Klein, C. and Krainc, D. (2011). Mitochondrial Parkin recruitment is impaired in neurons derived from mutant PINK1 induced pluripotent stem cells. J. Neurosci. 31, 5970-5976.
36. Soldner, F., Laganiére, J., Cheng, A. W., Hockemeyer, D., Gao, Q., Alagappan, R., Khurana, V., Golbe, L. I., Myers, R. H., Lindquist, S. et al. (2011). Generation of isogenic pluripotent stem cells differing exclusively at two early onset Parkinson point mutations. Cell 146, 318-331.
37. Srikanth, P. and Young-Pearse, T. L. (2014). Stem cells on the brain: modeling neurodevelopmental and neurodegenerative diseases using human induced pluripotent stem cells. J. Neurogenet. 28, 5-29.
38. Su, Y.-C. and Qi, X. (2013). Inhibition of excessive mitochondrial fission reduced aberrant autophagy and neuronal damage caused by LRRK2 G2019S mutation. Hum. Mol. Genet. 22, 4545-4561.
39. Suhr, S. T., Chang, E. A., Tjong, J., Alcasid, N., Perkins, G. A., Goissis, M. D., Ellisman, M. H., Perez, G. I. and Cibelli, J. B. (2010). Mitochondrial rejuvenation after induced pluripotency. PLoS ONE 5, e14095.
40. Takahashi, K. and Yamanaka, S. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663-676.
41. Wainger, B. J., Kiskinis, E., Mellin, C., Wiskow, O., Han, S. S. W., Sandoe, J., Perez, N. P., Williams, L. A., Lee, S., Boulting, G. et al. (2014). Intrinsic membrane hyperexcitability of amyotrophic lateral sclerosis patient-derived motor neurons. Cell Rep. 7, 1-11.
42. Woodard, C. M., Campos, B. A., Kuo, S.-H., Nirenberg, M. J., Nestor, M. W., Zimmer, M., Mosharov, E. V., Sulzer, D., Zhou, H., Paull, D. et al. (2014). iPSCderived dopamine neurons reveal differences between monozygotic twins discordant for Parkinson’s disease. Cell Rep. 9, 1173-1182.
43. Zhang, J., Lian, Q., Zhu, G., Zhou, F., Sui, L., Tan, C., Mutalif, R. A., Navasankari, R., Zhang, Y., Tse, H.-F. et al. (2011). A human iPSC model of Hutchinson Gilford Progeria reveals vascular smooth muscle and mesenchymal stem cell defects. Cell Stem Cell 8, 31-45.
44. Zhang, W., Li, J., Suzuki, K., Qu, J., Wang, P., Zhou, J., Liu, X., Ren, R., Xu, X., Ocampo, A. et al. (2015). A Werner syndrome stem cell model unveils heterochromatin alterations as a driver of human aging. Science 348, 1160-1163.